Role of hormone cofactors in the human papillomavirus-induced carcinogenesis of the uterine cervix

被引:35
作者
Delvenne, Philippe [1 ]
Herman, Ludivine [1 ]
Kholod, Natalia [1 ]
Caberg, Jean-Hubert [1 ]
Herfs, Michae [1 ]
Boniver, Jacques [1 ]
Jacobs, Nathalie [1 ]
Hubert, Pascale [1 ]
机构
[1] Univ Liege, CHU Sart Tilman, Dept Pathol, CRCE,CBIG, B-4000 Liege, Belgium
关键词
sexual hormones; human papillomavirus; metaplasia; carcinogenesis;
D O I
10.1016/j.mce.2006.10.014
中图分类号
Q2 [细胞生物学];
学科分类号
071009 [细胞生物学]; 090102 [作物遗传育种];
摘要
If human papillomavirus (HPV) is necessary for the development of (pre)neoplastic lesions of the uterine cervix, it is not sufficient. Among the cofactors involved in the malignant transformation of cells infected by HPV, sex hormones may facilitate the cervical carcinogenesis by different mechanisms, including the induction of squamous metaplasia in the transformation zone of the cervix, interactions between steroid hormones and HPV gene expression and alterations of the local immune microenvironment. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 67 条
[1]
Al-Saleh W, 1998, J PATHOL, V184, P283, DOI 10.1002/(SICI)1096-9896(199803)184:3<283::AID-PATH25>3.0.CO
[2]
2-K
[3]
ALSALEH W, 1995, VIRCHOWS ARCH, V427, P41
[4]
Chronic estrogen-induced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic mice [J].
Arbeit, JM ;
Howley, PM ;
Hanahan, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (07) :2930-2935
[5]
THE INTERACTION BETWEEN HPV INFECTION AND ESTROGEN METABOLISM IN CERVICAL CARCINOGENESIS [J].
AUBORN, KJ ;
WOODWORTH, C ;
DIPAOLO, JA ;
BRADLOW, HL .
INTERNATIONAL JOURNAL OF CANCER, 1991, 49 (06) :867-869
[6]
The regulatory E2 proteins of human genital papillomaviruses are pro-apoptotic [J].
Blachon, S ;
Demeret, C .
BIOCHIMIE, 2003, 85 (08) :813-819
[7]
Human retroviruses: Their role in cancer [J].
Blattner, WA .
PROCEEDINGS OF THE ASSOCIATION OF AMERICAN PHYSICIANS, 1999, 111 (06) :563-572
[8]
PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE [J].
BOSCH, FX ;
MANOS, MM ;
MUNOZ, N ;
SHERMAN, M ;
JANSEN, AM ;
PETO, J ;
SCHIFFMAN, MH ;
MORENO, V ;
KURMAN, R ;
SHAH, KV ;
ALIHONOU, E ;
BAYO, S ;
MOKHTAR, HC ;
CHICAREON, S ;
DAUDT, A ;
DELOSRIOS, E ;
GHADIRIAN, P ;
KITINYA, JN ;
KOULIBALY, M ;
NGELANGEL, C ;
TINTORE, LMP ;
RIOSDALENZ, JL ;
SARJADI ;
SCHNEIDER, A ;
TAFUR, L ;
TEYSSIE, AR ;
ROLON, PA ;
TORROELLA, M ;
TAPIA, AV ;
WABINGA, HR ;
ZATONSKI, W ;
SYLLA, B ;
VIZCAINO, P ;
MAGNIN, D ;
KALDOR, J ;
GREER, C ;
WHEELER, C .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11) :796-802
[9]
Differential response of estrogen receptors α and β to SP500263, a novel potent selective estrogen receptor modulator [J].
Brady, H ;
Doubleday, M ;
Gayo-Fung, LM ;
Hickman, M ;
Khammungkhune, S ;
Kois, A ;
Lipps, S ;
Pierce, S ;
Richard, N ;
Shevlin, G ;
Sutherland, MK ;
Anderson, DW ;
Bhagwat, SS ;
Stein, B .
MOLECULAR PHARMACOLOGY, 2002, 61 (03) :562-568
[10]
Estrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papillomavirus-transgenic mouse model [J].
Brake, T ;
Lambert, PF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (07) :2490-2495